Contact us

email: yezumwizasj@yahoo.com

Do you have a question? (+257) 22 25 33 16


SYM in the same vein as the MPHFA on the transition to a new HIV treatment schedule

Posted on 19/06/2019 - Category: Clinique Mobile ...

In November 2018, Ministry of Public Health and the Fight against AIDS (MPHFA) released an addendum on national guidelines for ARVs initiating the transition from ARV treatment to the new Dolutegravir-based therapy: Tenofovir / Lamivudine / Dolutegravir, known as TLD.

This treatment is for adults and teenagers over 35 pounds male and women over 49 years old.Service Yezu Mwiza followed suit with the MPHFA in implementing this approach through its Martin Royakers, S.J Clinic and by field trips with the Mobile Clinic.

Today we are reporting the case of MUTUMBA where the mobile clinic went for a monthly meeting in June.Out of 40 PLHIV on ARV treatment, 12 eligible patients were put on TLD. This has attracted the attention of PLHIV who are eager to discover this new treatment.

Note that according to WHO, TLD is recommended as a first-line alternative for HIV. Compared to other ARV molecules, this new treatment acts quickly in suppressing the viral load.

OUR PARTENERS